Cardium announces sales and distribution agreement with Academy Medical

Cardium Therapeutics announced a distribution agreement with Academy Medical to market, sell and distribute Excellagen to U.S. government medical providers, including the Veterans Administration healthcare system and military hospitals. Excellagen is FDA-cleared, to support advanced wound care in a broad range of dermal wounds. Academy Medical's initial focus will be to provide education and training on the use of Excellagen in the treatment of traumatic wounds, non-healing venous, pressure and diabetic ulcers, limb salvage, and post-Mohs skin cancer surgery and to support distribution within its growing customer base of over 35 VA and military hospitals within the U.S.

View Comments (0)